Ignite Creation Date:
2025-12-25 @ 2:41 AM
Ignite Modification Date:
2026-01-05 @ 9:39 PM
Study NCT ID:
NCT06465433
Status:
RECRUITING
Last Update Posted:
2025-12-10
First Post:
2024-06-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Extension Study to Provide Continued Treatment for Patients With Hematologic Malignancies Previously Enrolled in Studies With Tafasitamab
Sponsor:
Incyte Corporation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-11-08
Start Date Type:
ACTUAL
Primary Completion Date:
2027-08-29
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-08-29
Completion Date Type:
ESTIMATED
First Submit Date:
2024-06-13
First Submit QC Date:
None
Study First Post Date:
2024-06-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-04
Last Update Post Date:
2025-12-10
Last Update Post Date Type:
ESTIMATED